Cutler Group’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $70K | Sell |
4,646
-18,444
| -80% | -$335K | 0.02% | 552 |
|
|
2023
Q4 | $497K | Sell |
23,090
-47,302
| -67% | -$873K | 0.04% | 424 |
|
|
2023
Q3 | $1.31M | Buy |
70,392
+28,951
| +70% | +$676K | 0.13% | 175 |
|
|
2023
Q2 | $1.05M | Buy |
41,441
+30,235
| +270% | +$761K | 0.15% | 163 |
|
|
2023
Q1 | $290K | Buy |
11,206
+2,488
| +29% | +$66.6K | 0.03% | 526 |
|
|
2022
Q4 | $206K | Sell |
8,718
-15,566
| -64% | -$420K | 0.02% | 775 |
|
|
2022
Q3 | $615K | Buy |
24,284
+14,002
| +136% | +$491K | 0.04% | 451 |
|
|
2022
Q2 | $341K | Sell |
10,282
-24,748
| -71% | -$1.05M | 0.02% | 704 |
|
|
2022
Q1 | $2.53M | Sell |
35,030
-24,811
| -41% | -$1.79M | 0.13% | 163 |
|
|
2021
Q4 | $5.49M | Sell |
59,841
-46
| -0.1% | -$5.5K | 0.23% | 83 |
|
|
2021
Q3 | $7.59M | Buy |
59,887
+40,077
| +202% | +$5.83M | 0.34% | 45 |
|
|
2021
Q2 | $3.29M | Sell |
19,810
-32,276
| -62% | -$5.23M | 0.15% | 135 |
|
|
2021
Q1 | $9.47M | Buy |
52,086
+52,085
| +5,208,500% | +$12.1M | 0.47% | 25 |
|
|
2020
Q4 | $0 | Buy |
+1
| New | +$203 | ﹤0.01% | 5475 |
|
|
2020
Q3 | – | Sell |
-8,485
| Closed | -$1.8M | – | 5249 |
|
|
2020
Q2 | $1.62M | Sell |
8,485
-8,098
| -49% | -$1.42M | 0.11% | 201 |
|
|
2020
Q1 | $2.57M | Buy |
16,583
+1,569
| +10% | +$183K | 0.13% | 147 |
|
|
2019
Q4 | $1.26M | Sell |
15,014
-5,851
| -28% | -$445K | 0.08% | 213 |
|
|
2019
Q3 | $1.41M | Buy |
20,865
+12,136
| +139% | +$799K | 0.13% | 130 |
|
|
2019
Q2 | $579K | Buy |
8,729
+106
| +1% | +$6.18K | 0.05% | 313 |
|
|
2019
Q1 | $479K | Sell |
8,623
-1,107
| -11% | -$67.6K | 0.05% | 325 |
|
|
2018
Q4 | $482K | Buy |
9,730
+7,403
| +318% | +$453K | 0.05% | 342 |
|
|
2018
Q3 | $200K | Buy |
2,327
+738
| +46% | +$52.6K | 0.01% | 833 |
|
|
2018
Q2 | $92K | Buy |
+1,589
| New | +$77.6K | 0.01% | 1206 |
|
|
2018
Q1 | – | Sell |
-200
| Closed | -$7.55K | – | 5186 |
|
|
2017
Q4 | $6K | Sell |
200
-2,776
| -93% | -$92.2K | ﹤0.01% | 3521 |
|
|
2017
Q3 | $98K | Buy |
2,976
+2,932
| +6,664% | +$96.1K | ﹤0.01% | 1691 |
|
|
2017
Q2 | $1K | Sell |
44
-2,258
| -98% | -$65.8K | ﹤0.01% | 6042 |
|
|
2017
Q1 | $57K | Buy |
2,302
+1,702
| +284% | +$35.4K | ﹤0.01% | 2281 |
|
|
2016
Q4 | $9K | Sell |
600
-1,700
| -74% | -$28.9K | ﹤0.01% | 4350 |
|
|
2016
Q3 | $42K | Buy |
2,300
+1,700
| +283% | +$29.8K | ﹤0.01% | 2634 |
|
|
2016
Q2 | $9K | Sell |
600
-3,289
| -85% | -$38.4K | ﹤0.01% | 4303 |
|
|
2016
Q1 | $37K | Buy |
+3,889
| New | +$55.2K | ﹤0.01% | 2638 |
|
Other funds holding TDOC
AIM
NAMA
Cutler Group's TDOC Position: Q1 2024 in Review
Cutler Group reduced its Teladoc Health (TDOC) stake by 80% in Q1 2024, selling an estimated $335K and leaving 4,646 shares worth $70K. The position accounts for 0.02% of the portfolio, ranked #552.
Cutler Group first reported a position in TDOC in Q1 2016 and has held it in 31 quarters since. The position peaked at $9.47M in Q1 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.
- Cutler Group held 4,646 shares of Teladoc Health worth $70K as of Q1 2024.
- Cutler Group sold 18,444 Teladoc Health shares in Q1 2024, an estimated $335K.
- Teladoc Health made up 0.02% of Cutler Group's portfolio in Q1 2024, its #552 holding.
- Cutler Group first reported a position in Teladoc Health in Q1 2016 and has held it in 31 quarters since.
- Cutler Group's Teladoc Health position peaked at $9.47M in Q1 2021.
- 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.